Related Experiment Videos
Germline p53 mutation in a patient with multiple primary cancers.
K Kimura1, K Shinmura, T Hasegawa
1Biology Division, National Cancer Center Research Institute, Tokyo, Japan.
Japanese Journal of Clinical Oncology
|August 24, 2001
Summary
A rare germline p53 gene mutation at codon 106 was identified in a Japanese female with multiple primary cancers. This finding may link p53 mutation sites to cancer development and outcomes.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Germline mutations in tumor suppressor genes, such as TP53, are associated with hereditary cancer syndromes.
- Understanding the specific mutations and their clinical correlations is crucial for risk assessment and personalized medicine.
Observation:
- A Japanese female patient presented with a history of five distinct primary cancers.
- Genetic analysis of non-cancerous tissue revealed a novel germline missense mutation in the TP53 gene at codon 106 (Ser106Arg).
Findings:
- This represents the first documented instance of a germline TP53 mutation specifically at codon 106.
- The identified mutation (AGC to AGG) occurred in the DNA of the patient's non-cancerous breast tissue.
Implications:
- This case provides a unique opportunity to study the genotype-phenotype correlations of TP53 mutations.
- Further research can explore how specific TP53 mutation locations influence cancer type, susceptibility, and clinical presentation.
- Establishing these correlations may improve early detection and therapeutic strategies for individuals with hereditary cancer predispositions.